MILPHARM ApS: Financial statements 2021
CVR: 35814159
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
MILPHARM ApS (CVR 35814159) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -1,867 and a net result of DKK 175,681 compared with DKK 274,792 the year before. Equity in the 2021 report amounted to DKK 614,869. The solvency ratio was 46.8%.
- Gross Profit
- DKK -1,867
- Profit/Loss
- DKK 175,681
- Equity
- DKK 614,869
- Total Assets
- DKK 1,313,472
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -2 t. | 176 t. | 615 t. | 0 |
| 2020 | - | -10 t. | 275 t. | 439 t. | 0 |
| 2019 | - | -8 t. | 91 t. | 164 t. | 0 |
| 2018 | - | -8 t. | -86 t. | 73 t. | - |
| 2017 | - | -7 t. | -10 t. | 160 t. | - |
Official annual report
Find more companies like MILPHARM ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout MILPHARM ApS
MILPHARM ApS was a Danish company of the type Anpartsselskab based in Slagelse, founded in 2014. The company has been dissolved on 24 June 2022. The company was registered under the industry Investeringsselskaber. According to the 2021 annual report, the company had an average of 0 employees. In 2021, the company reported a gross profit of DKK -1,867 and a net result of DKK 175,681 compared with DKK 274,792 the year before. Equity in the 2021 report amounted to DKK 614,869.